Voronoi, Inc. (KOSDAQ:310210)
South Korea · Delayed Price · Currency is KRW 123,200
+9,900 (8.74%)
Oct 16, 2026, 3:30 PM KST
Voronoi Revenue
Voronoi had revenue of 4.16B KRW in the twelve months ending June 30, 2026, up 24.23% year-over-year. In the year 2025, Voronoi had annual revenue of 7.51B. That makes Voronoi the 41,346th largest company in the world by revenue and 2,536th in South Korea.
Revenue (ttm)
4.16B
Revenue Growth
+24.23%
P/S Ratio
536.74
Revenue / Employee
24.63M
Employees
169
Market Cap
2.23T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.51B | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 9.77B | -5.02B | -33.93% |
| Dec 31, 2021 | 14.78B | 8.60B | 139.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SK Biopharmaceuticals | 861.34B |
| SK bioscience | 659.27B |
| Hugel | 479.57B |
| LigaChem Biosciences | 98.78B |
| HLB Co., Ltd. | 97.47B |
| Komipharm International | 53.02B |
| ABL Bio | 34.28B |
| OliX Pharmaceuticals | 13.64B |